These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Extensive expertise in endocrinology: advances in the management of glucocorticoid-induced osteoporosis. Compston JE Eur J Endocrinol; 2023 Mar; 188(3):R46-R55. PubMed ID: 36880157 [TBL] [Abstract][Full Text] [Related]
24. Glucocorticoid-induced osteoporosis. Silverman SL; Lane NE Curr Osteoporos Rep; 2009 Mar; 7(1):23-6. PubMed ID: 19239826 [TBL] [Abstract][Full Text] [Related]
25. An update on glucocorticoid-induced osteoporosis. Lane NE Rheum Dis Clin North Am; 2001 Feb; 27(1):235-53. PubMed ID: 11285998 [TBL] [Abstract][Full Text] [Related]
26. Management of bone disease in patients on long term glucocorticoid therapy. Compston JE Gut; 1999 Jun; 44(6):770-2. PubMed ID: 10323872 [No Abstract] [Full Text] [Related]
28. Monitoring and management of bone status in patients on chronic glucocorticoid treatment--the Medscheme experience. Rothberg AD; Matshidze PK S Afr Med J; 2000 Nov; 90(11):1125-9. PubMed ID: 11196035 [TBL] [Abstract][Full Text] [Related]
29. [Secondary osteoporosis. Glucocorticoid induced osteoporosis in childhood : prophylaxis and treatment]. Tanaka H Clin Calcium; 2007 Jul; 17(7):1114-9. PubMed ID: 17607080 [TBL] [Abstract][Full Text] [Related]
31. [Glucocorticoid and Bone. Efficacy of active vitamin D on glucocorticoid-induced osteoporosis]. Miki T; Okamoto K Clin Calcium; 2014 Sep; 24(9):1387-92. PubMed ID: 25177012 [TBL] [Abstract][Full Text] [Related]
33. Glucocorticoid-induced osteoporosis: pathophysiological role of GH/IGF-I and PTH/VITAMIN D axes, treatment options and guidelines. Mazziotti G; Formenti AM; Adler RA; Bilezikian JP; Grossman A; Sbardella E; Minisola S; Giustina A Endocrine; 2016 Dec; 54(3):603-611. PubMed ID: 27766553 [TBL] [Abstract][Full Text] [Related]
34. How to prevent steroid induced osteoporosis. Sambrook PN Ann Rheum Dis; 2005 Feb; 64(2):176-8. PubMed ID: 15647424 [TBL] [Abstract][Full Text] [Related]
35. Glucocorticoid osteoporosis--mechanisms and management. Reid IR Eur J Endocrinol; 1997 Sep; 137(3):209-17. PubMed ID: 9330580 [TBL] [Abstract][Full Text] [Related]
36. [Activate vitamin D3 or bisphosphonate in glucocorticoid-induced osteoporosis]. Imanishi Y; Nishizawa Y Clin Calcium; 2006 Nov; 16(11):1844-50. PubMed ID: 17079851 [TBL] [Abstract][Full Text] [Related]
37. [Glucocorticoid-induced osteoporosis]. Tóth M; Tulassay Z Orv Hetil; 2000 Jan; 141(5):219-23. PubMed ID: 10697979 [TBL] [Abstract][Full Text] [Related]
38. Prevention and treatment of bone changes associated with exposure to glucocorticoids. Warriner AH; Saag KG Curr Osteoporos Rep; 2013 Dec; 11(4):341-7. PubMed ID: 24097304 [TBL] [Abstract][Full Text] [Related]
39. Treatment of osteoporosis and Paget's disease. Stewart GO; Nicholson GC Curr Opin Rheumatol; 1991 Jun; 3(3):380-7. PubMed ID: 1883692 [TBL] [Abstract][Full Text] [Related]
40. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options. De Nijs RN Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]